Anna Morelli

2.3k total citations · 1 hit paper
18 papers, 2.0k citations indexed

About

Anna Morelli is a scholar working on Physiology, Immunology and Molecular Biology. According to data from OpenAlex, Anna Morelli has authored 18 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 7 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Anna Morelli's work include Adenosine and Purinergic Signaling (12 papers), Mast cells and histamine (3 papers) and Immune Cell Function and Interaction (3 papers). Anna Morelli is often cited by papers focused on Adenosine and Purinergic Signaling (12 papers), Mast cells and histamine (3 papers) and Immune Cell Function and Interaction (3 papers). Anna Morelli collaborates with scholars based in Italy, Germany and United States. Anna Morelli's co-authors include Francesco Di Virgilio, Paola Chiozzi, Simonetta Falzoni, Davide Ferrari, Olavio R. Baricordi, Juana María Sanz, M Torboli, Anna Solini, R. Fellin and Stefan Dichmann and has published in prestigious journals such as Blood, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Anna Morelli

18 papers receiving 2.0k citations

Hit Papers

Nucleotide receptors: an emerging family of regulatory mo... 2001 2026 2009 2017 2001 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Morelli Italy 16 1.3k 599 595 224 196 18 2.0k
Joan H.F. Drosopoulos United States 17 1.0k 0.8× 274 0.5× 183 0.3× 82 0.4× 112 0.6× 22 1.6k
Elisa Orioli Italy 17 712 0.5× 408 0.7× 260 0.4× 53 0.2× 140 0.7× 21 1.2k
Julio C. Morote–Garcia Germany 12 719 0.5× 526 0.9× 323 0.5× 166 0.7× 22 0.1× 17 1.7k
Anna E. Goldstein United States 22 1.3k 1.0× 788 1.3× 768 1.3× 119 0.5× 21 0.1× 34 2.5k
Doris Kloor Germany 19 468 0.4× 476 0.8× 158 0.3× 60 0.3× 16 0.1× 35 1.2k
Patrycja Koszałka Poland 12 472 0.4× 224 0.4× 119 0.2× 67 0.3× 41 0.2× 33 766
Zaichuan Mi United States 24 818 0.6× 666 1.1× 56 0.1× 72 0.3× 19 0.1× 72 1.8k
D Vincent United States 12 545 0.4× 426 0.7× 86 0.1× 111 0.5× 12 0.1× 26 2.0k
Lawrence A. Lockman United States 23 155 0.1× 1.0k 1.7× 179 0.3× 18 0.1× 22 0.1× 36 2.3k
Daria V. Ilatovskaya United States 28 73 0.1× 1.1k 1.9× 157 0.3× 60 0.3× 21 0.1× 93 2.2k

Countries citing papers authored by Anna Morelli

Since Specialization
Citations

This map shows the geographic impact of Anna Morelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Morelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Morelli more than expected).

Fields of papers citing papers by Anna Morelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Morelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Morelli. The network helps show where Anna Morelli may publish in the future.

Co-authorship network of co-authors of Anna Morelli

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Morelli. A scholar is included among the top collaborators of Anna Morelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Morelli. Anna Morelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Popescu, Iulia, Camila Macedo, Kareem Abu‐Elmagd, et al.. (2007). EBV-Specific CD8+ T Cell Reactivation in Transplant Patients Results in Expansion of CD8+ Type-1 Regulatory T Cells. American Journal of Transplantation. 7(5). 1215–1223. 32 indexed citations
2.
Solini, Anna, Paola Chiozzi, Anna Morelli, et al.. (2004). Enhanced P2X7Activity in Human Fibroblasts From Diabetic Patients. Arteriosclerosis Thrombosis and Vascular Biology. 24(7). 1240–1245. 45 indexed citations
3.
Morelli, Anna, Paola Chiozzi, Anna Maria Chiesa, et al.. (2003). Extracellular ATP Causes ROCK I-dependent Bleb Formation in P2X7-transfected HEK293 Cells. Molecular Biology of the Cell. 14(7). 2655–2664. 116 indexed citations
4.
Solini, Anna, Paola Chiozzi, Anna Morelli, et al.. (2003). Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport. Journal of Cellular Physiology. 197(3). 435–444. 26 indexed citations
5.
Baraldi, Pier Giovanni, Marı́a del Carmen Núñez, Anna Morelli, et al.. (2003). Synthesis and Biological Activity of N-Arylpiperazine-Modified Analogues of KN-62, a Potent Antagonist of the Purinergic P2X7 Receptor. Journal of Medicinal Chemistry. 46(8). 1318–1329. 61 indexed citations
6.
Idzko, Marco, Elisabeth Panther, Silvia Corinti, et al.. (2002). Sphingosine 1‐phosphate induces Chemotaxis of immature dendritic cells and modulates cytokine‐release in mature human dendritic cells for emergence of Th2 immune responses. The FASEB Journal. 16(6). 625–627. 167 indexed citations
7.
Adinolfi, Elena, Loredana Melchiorri, Simonetta Falzoni, et al.. (2002). P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood. 99(2). 706–708. 171 indexed citations
8.
Gessi, Stefania, Stefania Merighi, Anna Morelli, et al.. (2001). Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. British Journal of Pharmacology. 134(1). 116–126. 96 indexed citations
9.
Virgilio, Francesco Di, Paola Chiozzi, Davide Ferrari, et al.. (2001). Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood. 97(3). 587–600. 613 indexed citations breakdown →
10.
Morelli, Anna, et al.. (2001). Proapoptotic plasma membrane pore: P2X7 receptor. Drug Development Research. 52(4). 571–578. 12 indexed citations
11.
Solini, Anna, Paola Chiozzi, Simonetta Falzoni, et al.. (2000). High glucose modulates P2X 7 receptor-mediated function in human primary fibroblasts. Diabetologia. 43(10). 1248–1256. 46 indexed citations
12.
Ferrari, Davide, Andrea Sala, Paola Chiozzi, et al.. (2000). The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. The FASEB Journal. 14(15). 2466–2476. 145 indexed citations
13.
Solini, Anna, Paola Chiozzi, Anna Morelli, R. Fellin, & Francesco Di Virgilio. (1999). Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. Journal of Cell Science. 112(3). 297–305. 135 indexed citations
14.
Falzoni, Simonetta, Davide Ferrari, Paola Chiozzi, et al.. (1999). Mouse Dendritic Cells Express the P2X7 Purinergic Receptor: Characterization and Possible Participation in Antigen Presentation. The Journal of Immunology. 163(4). 1958–1965. 131 indexed citations
15.
Rondelli, Damiano, Donatella Raspadori, Claudio Anasetti, et al.. (1998). Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplantation. 22(7). 631–637. 82 indexed citations
16.
Visani, Giuseppe, Patrizia Tosi, Emanuela Ottaviani, et al.. (1996). All‐trans retinoic acid and in vitro cytokine production by acute promyelocytic eukemia cells. European Journal Of Haematology. 57(4). 301–306. 12 indexed citations
17.
Zinzani, Pier Luigi, Alfonso Zaccaria, Giuseppe Visani, et al.. (1996). Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low‐grade non‐Hodgkin's lymphoma. European Journal Of Haematology. 57(5). 335–340. 21 indexed citations
18.
Flora, Silvio De, et al.. (1985). Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.. PubMed. 45(7). 3188–96. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026